{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:14:02Z","timestamp":1773288842798,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.leukres.2010.02.013","type":"journal-article","created":{"date-parts":[[2010,3,15]],"date-time":"2010-03-15T09:35:20Z","timestamp":1268645720000},"page":"e160-e163","source":"Crossref","is-referenced-by-count":7,"title":["Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Mesut","family":"Seker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bala Basak Oven","family":"Ustaalio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Bilici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut Emre","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umut","family":"Kefeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagehan Ozdemir","family":"Barisik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismet","family":"Tamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmut","family":"Gumus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2010.02.013_bib1","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.013_bib2","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO\u2013EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2010.02.013_bib3","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Italian study group for cutaneous lymphomas prognostic factors in primary cutaneous B-cell lymphoma","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.02.013_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2559.1993.tb00469.x","article-title":"Cutaneous immunocytomas: a clinicopathologic study of 26 cases","volume":"23","author":"Rijlaarsdam","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/j.leukres.2010.02.013_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/path.1426","article-title":"Infrequent somatic Fas mutations but no evidence of Bcl-10 mutations or t(11;18) in primary cutaneous MALT-type lymphoma","volume":"201","author":"Gronbaek","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.leukres.2010.02.013_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/01.cco.0000239879.31463.42","article-title":"Primary cutaneous B-cell lymphoma: classification and treatment","volume":"16","author":"Willemze","year":"2006","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.leukres.2010.02.013_bib7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2004.08.044","article-title":"Primary cutaneous B-cell lymphomas treated with radiotherapy: a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification systems","volume":"22","author":"Smith","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2010.02.013_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0167-8140(99)00089-4","article-title":"Radiotherapy in the management of cutaneous B-cell lymphoma: our experience in 25 cases","volume":"52","author":"Kirova","year":"1999","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.leukres.2010.02.013_bib9","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ctrv.2005.05.007","article-title":"Tolerability and safety of rituximab (MabThera)","volume":"31","author":"Kimby","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.leukres.2010.02.013_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/annonc\/mdn636","article-title":"Rituximab monotherapy for primary cutaneous B-cell lymphoma: response and follow-up in 16 patients","volume":"20","author":"Valencak","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.leukres.2010.02.013_bib11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jaad.2008.08.005","article-title":"Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab","volume":"59","author":"Morales","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.leukres.2010.02.013_bib12","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/j.1365-2133.2006.07523.x","article-title":"Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases","volume":"155","author":"Kerl","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2010.02.013_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2133.2005.06659.x","article-title":"Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas-an applicational observation","volume":"153","author":"Gellrich","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.leukres.2010.02.013_bib14","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/000155501750376339","article-title":"Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody","volume":"81","author":"Soda","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.leukres.2010.02.013_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001050051291","article-title":"Anti-CD20 antibodies in primary cutaneous B-cell lymphoma. Initial results in dermatologic patients","volume":"52","author":"Gellrich","year":"2001","journal-title":"Hautarzt"},{"key":"10.1016\/j.leukres.2010.02.013_bib16","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/j.leukres.2008.05.018","article-title":"Conjunctival malt lymphoma successfully treated with single agent rituximab therapy","volume":"33","author":"Salepci","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.02.013_bib17","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1016\/j.leukres.2009.03.026","article-title":"Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma","volume":"33","author":"Seker","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2010.02.013_bib18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1385\/MO:21:1:67","article-title":"Reactivation of hepatitis B virus infection with cytotoxic therapy in non-Hodgkin's lymphoma","volume":"21","author":"Ozguroglu","year":"2004","journal-title":"Med Oncol"},{"key":"10.1016\/j.leukres.2010.02.013_bib19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1517\/14740338.4.3.599","article-title":"Reactivation of hepatitis B virus with rituximab","volume":"4","author":"Tsutsumi","year":"2005","journal-title":"Expert Opin Drug Saf"},{"issue":"106","key":"10.1016\/j.leukres.2010.02.013_bib20","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/cncr.21701","article-title":"Lamivudine prophylaxis reduces the incidence and severity of hepatitis in hepatitis B virus carriers who receive chemotherapy for lymphoma","volume":"15","author":"Li","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.leukres.2010.02.013_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.leukres.2010.02.013_bib22","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/jac\/dki114","article-title":"Lamivudine prophylaxis in HBV carriers with haemato-oncological malignancies who receive chemotherapy","volume":"55","author":"Idilman","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.leukres.2010.02.013_bib23","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2133.2006.07451.x","article-title":"Late lethal hepatitis B virus reactivation after rituximab treatment of low-grade cutaneous B-cell lymphoma","volume":"155","author":"Perceau","year":"2006","journal-title":"Br J Dermatol"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212610000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T16:27:11Z","timestamp":1544632031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212610000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0145212610000949"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2010.02.013","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}